Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Recruiting · NCT07144254 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 1 | 2026-06-02 | NCT07144254 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Emory University | 393 |
| Iterion Therapeutics | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arthur M. Blank Children's Healthcare of Atlanta | Atlanta | United States | 2 |